๐Sulindac
โ has become the NSAID of choice in some
centres for patients with renal impairment because of
reports of its renal sparing effects.
โ There is evidence
that this sparing effect is dose-related and is lost if
doses above 100 mg twice daily are used.
#Basel
Renal handbook
https://t.me/pharma_Note
โ has become the NSAID of choice in some
centres for patients with renal impairment because of
reports of its renal sparing effects.
โ There is evidence
that this sparing effect is dose-related and is lost if
doses above 100 mg twice daily are used.
#Basel
Renal handbook
https://t.me/pharma_Note
Telegram
Good pharmacists..โ๐๐จโโ
๐ฐ ููุงู ุชุญุชูู ุนูู ู
ุนููู
ุงุช_ ุทุจูุฉ ุญูู ุงูุงุฏููู ูุชุดุฎูุต ุงูุญุงูุงุช ุงูุณุฑูุฑูุฉ..๐๐๐จโโ.
ุฑุงุจุท ุงูููุงุฉ..
https://t.me/pharma_Note
ููุชูุงุตู ู ุน ุงูุฃุฏู ู :
@Basel_Alafif
ุฑุงุจุท ุงูููุงุฉ..
https://t.me/pharma_Note
ููุชูุงุตู ู ุน ุงูุฃุฏู ู :
@Basel_Alafif
โค4๐2
๐Which ARBs in "what if scenarios?
โ Enteropathyยป
All but olmesartan
โ gout-drug induced hepatotoxicityยป losartan, irbesartan
โ DM, Obesity, non alcohol fatty liverยป
Telimisartan, azilsartan
โ liver impairmentยป all but losartan
โ renal stones, polypharmacyยป
All but losartan
โ non compliantยป azilsartan
โ non-dipper, morning surge in BPยป
Telimsartan, irbesartan, candedsartan
#Basel
https://t.me/pharma_
โ Enteropathyยป
All but olmesartan
โ gout-drug induced hepatotoxicityยป losartan, irbesartan
โ DM, Obesity, non alcohol fatty liverยป
Telimisartan, azilsartan
โ liver impairmentยป all but losartan
โ renal stones, polypharmacyยป
All but losartan
โ non compliantยป azilsartan
โ non-dipper, morning surge in BPยป
Telimsartan, irbesartan, candedsartan
#Basel
https://t.me/pharma_
๐6โค2
โ๏ธูููุงุฆุฏุฉ ููุงู ุทุฑููุฉ ูุญุณุงุจ
antidote for heparin
โ ุงููุง ูุงุฒู ูุดูู ูู ูุฉ ุงูููุจุงุฑูู ุงูู ุนุทุงู ุงุฎุฑ ุณุงุนุชูู ุงูู ุซูุงุซ ุณุงุนุงุช.. ุซู
ูุนุทู ูุตููุง ุจุงูุฅุถุงูุฉ ูุนูู
ุซู ุฑุจุนูุง!
โป๏ธูู ุซูุง ูู ู ุฑูุถ ุจูุฃุฎุฐ 1000unite /h
ูู ุจุชููู ุฌุฑุนุฉ protamine ููุง ุ
ุจูููู 1000+500+250=1750unite
ูุงูู ุนุฑูู ุงู ูู ูุญุฏู ู ู ุงูููุจุงุฑูู ุจูุบุทููุง ุจ100mg ู ู protamine
ุงุฐุง 1750รท100=17.5mg
ูุจุงูุชุงูู ุงูุฌุฑุนุฉ ููุง ุจุชููู 17.5mg
๐ ู ูุญูุธู
ุงููุง ุงูmaximum dose 50mg
ุจุฅุณุชุซูุงุก CABG
๐ ุฃูุถุง ู ู ูู ูุนุชู ุฏ ุน ุงูููุช ูู ูุงู ู ุนุฑูู ูู ุง ู ูุถุญ ุจุงูุตูุฑุฉ ุงูุชุงูู๐
#Basel
https://t.me/pharma_Note
antidote for heparin
โ ุงููุง ูุงุฒู ูุดูู ูู ูุฉ ุงูููุจุงุฑูู ุงูู ุนุทุงู ุงุฎุฑ ุณุงุนุชูู ุงูู ุซูุงุซ ุณุงุนุงุช.. ุซู
ูุนุทู ูุตููุง ุจุงูุฅุถุงูุฉ ูุนูู
ุซู ุฑุจุนูุง!
โป๏ธูู ุซูุง ูู ู ุฑูุถ ุจูุฃุฎุฐ 1000unite /h
ูู ุจุชููู ุฌุฑุนุฉ protamine ููุง ุ
ุจูููู 1000+500+250=1750unite
ูุงูู ุนุฑูู ุงู ูู ูุญุฏู ู ู ุงูููุจุงุฑูู ุจูุบุทููุง ุจ100mg ู ู protamine
ุงุฐุง 1750รท100=17.5mg
ูุจุงูุชุงูู ุงูุฌุฑุนุฉ ููุง ุจุชููู 17.5mg
๐ ู ูุญูุธู
ุงููุง ุงูmaximum dose 50mg
ุจุฅุณุชุซูุงุก CABG
๐ ุฃูุถุง ู ู ูู ูุนุชู ุฏ ุน ุงูููุช ูู ูุงู ู ุนุฑูู ูู ุง ู ูุถุญ ุจุงูุตูุฑุฉ ุงูุชุงูู๐
#Basel
https://t.me/pharma_Note
๐1
โ๏ธRemember
alpha-blockers should generally not be
used as initial agents to treat hypertensionโ
โ๏ธexcept perhaps
in men with symptomatic prostatism or nightmares linked
to PTSD.
#Basel
Current medication 2024
alpha-blockers should generally not be
used as initial agents to treat hypertensionโ
โ๏ธexcept perhaps
in men with symptomatic prostatism or nightmares linked
to PTSD.
#Basel
Current medication 2024
โ๏ธRemember
โ Resistant hypertension:
Uncontrolled BP despite use of maximally tolerated dose of 3 antihypertensive drugs including diuretics.
โ Refractory hypertension:
Uncontrolled BP despite use of 5 or more antihypertensive agent of different classes including along acting thiazide like diuretic and an MR mineralocorticoid receptor antagonist at maximal or maximally tolerated dose .
#Basel
โ Resistant hypertension:
Uncontrolled BP despite use of maximally tolerated dose of 3 antihypertensive drugs including diuretics.
โ Refractory hypertension:
Uncontrolled BP despite use of 5 or more antihypertensive agent of different classes including along acting thiazide like diuretic and an MR mineralocorticoid receptor antagonist at maximal or maximally tolerated dose .
#Basel
๐2
โ๏ธRemember
โ Maximum time allowed for thrombolytic therapy in STEMI is 24h
โ Maximum time allowed for primary PCI in stable STEMI patients is 48h
#Basel
โ Maximum time allowed for thrombolytic therapy in STEMI is 24h
โ Maximum time allowed for primary PCI in stable STEMI patients is 48h
#Basel
โ๏ธRemember
โ Normal D-Dimer value for male patient above 50 years can be calculated as
Age *10 ug/L
#Basel
โ Normal D-Dimer value for male patient above 50 years can be calculated as
Age *10 ug/L
#Basel
๐3
โ๏ธ in UTI infection
Asymptomatic bacteriuria need to be treated only in:
โ pregnant women
โ patients undergoing urological intervention
โ renal transplant recipients in the first few months after transplant
#Basel
Asymptomatic bacteriuria need to be treated only in:
โ pregnant women
โ patients undergoing urological intervention
โ renal transplant recipients in the first few months after transplant
#Basel
๐5
โซThe definition of nephrotoxicity for vancomycin :
โ๏ธGenerally defined as minimum of 2 to 3 consecutive documented increases in serum creatinine levels:
1๏ธโฃIncrease of 0.5mg/ml for patients with scr WNL or
2๏ธโฃIncrease greater than 20%from baseline (especially for patients with abnormal baseline creatinine)
#Basel
IDSA
โ๏ธGenerally defined as minimum of 2 to 3 consecutive documented increases in serum creatinine levels:
1๏ธโฃIncrease of 0.5mg/ml for patients with scr WNL or
2๏ธโฃIncrease greater than 20%from baseline (especially for patients with abnormal baseline creatinine)
#Basel
IDSA
โค1๐1๐1
โ๏ธFosinopril is the only phosphinate-containing ACE inhibitor
โ๏ธ In contrast to other ACE inhibitors, fosinopril is eliminated from
the body via both renal and hepatic pathways, which make it a safer choice in patients
with impaired kidney function.
โ๏ธ In contrast to other ACE inhibitors, fosinopril is eliminated from
the body via both renal and hepatic pathways, which make it a safer choice in patients
with impaired kidney function.
โ๏ธTo administer Aminoglycoside antibiotics, for total dosing
โ For patientโs having weight is 1-1.2 times their ideal body weight, ideal body
weight is used.
โ For patients whose weighs more than 1.2 times ideal body weight, use adjusted
body weight is used
โ For patientโs having weight is 1-1.2 times their ideal body weight, ideal body
weight is used.
โ For patients whose weighs more than 1.2 times ideal body weight, use adjusted
body weight is used
โค2๐1
โ๏ธIn CKD the tubular secretory capacity for a diuretics is lowered offern in parallel with the reduction in GFR ,thus higher blood levels are required to effect tubular delivery sufficient to prompt a diuresis
ููุฐุง ุชูุถูุญ ููุณุคุงู ุงูุชุงูู..
ูู ุงุฐุง ูุฒูุฏ ุฌุฑุนู ุงูู ุฏุฑ ููู ุง ูู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู ุจุฎูุงู ุงูุนุงุฏุฉ ุงูู ูููุต ูููุง ุฌุฑุนุฉ ุงูุฏูุงุก ุนูุฏู ุง ููู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู.
#Basel
ููุฐุง ุชูุถูุญ ููุณุคุงู ุงูุชุงูู..
ูู ุงุฐุง ูุฒูุฏ ุฌุฑุนู ุงูู ุฏุฑ ููู ุง ูู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู ุจุฎูุงู ุงูุนุงุฏุฉ ุงูู ูููุต ูููุง ุฌุฑุนุฉ ุงูุฏูุงุก ุนูุฏู ุง ููู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู.
#Basel
โบInitial loop diuretics dosing in patients hospitalized with HF and congestion :
1โฃ For patientโs on long term 2.5ร their outpatient dose on a mg per mg basis ,demonstrated safety and efficacy
2โฃfor patients not receiving long term 40-80mg IV BID of furosemide or the equivalent .
ูุชูุถูุญ ุฑูู ูุงุญุฏ..
ูู ูุงู ุจูุฃุฎุฐ 40mg orally BIDู ุฑุชูู ุจุงูููู ุจุชููู
ุงูุฌุฑุนุฉ 100mg IV BID
ุงููุฏู ูู ูุน post dosing or post diurteic Na retention
ุงู ู ุง ุชู ุณู ุฃูุถุง
braking phenomenon
#Basel
https://t.me/pharma_Note
1โฃ For patientโs on long term 2.5ร their outpatient dose on a mg per mg basis ,demonstrated safety and efficacy
2โฃfor patients not receiving long term 40-80mg IV BID of furosemide or the equivalent .
ูุชูุถูุญ ุฑูู ูุงุญุฏ..
ูู ูุงู ุจูุฃุฎุฐ 40mg orally BIDู ุฑุชูู ุจุงูููู ุจุชููู
ุงูุฌุฑุนุฉ 100mg IV BID
ุงููุฏู ูู ูุน post dosing or post diurteic Na retention
ุงู ู ุง ุชู ุณู ุฃูุถุง
braking phenomenon
#Basel
https://t.me/pharma_Note
๐4
โ๏ธManagement of resistant HTN: Progress to next step if blood pressure remains uncontrolled
1โฃStep 1
โป๏ธ Exclude causes of HTN:
secondary causes, white-coat effect, medication nonadherence
โป๏ธ Maximize lifestyle interventions: low-sodium diet (<2400 mg/day), at least 6 hours/night of
uninterrupted sleep, weight loss, exercise)
โป๏ธOptimize three-drug regimen of CCB, RAS inhibitor, and diuretic (appropriately dosed for
renal function) at maximally tolerated doses.
2โฃStep 2: Substitute optimally dosed thiazide diuretic (chlorthalidone or indapamide) for previous diuretic
3โฃStep 3: Add mineralocorticoid (aldosterone) receptor antagonist: spironolactone or eplerenone
4โฃStep 4:
๐ดIf heart rate โฅ70 beats/min, add ฮฒ-blocker
๐ดIf ฮฒ-blocker is contraindicated, add central ฮฑ1-agonist (clonidine or guanfacine)
5โฃStep 5: Add hydralazine and titrate to maximal dose (use concomitantly with a ฮฒ-blocker and diuretic)
6โฃStep 6: Substitute minoxidil for hydralazine and titrate
7โฃStep 7: Refer to HTN specialist or ongoing clinical trial
#BASEL
#ACCP -ASHP - Cardiology 2023
1โฃStep 1
โป๏ธ Exclude causes of HTN:
secondary causes, white-coat effect, medication nonadherence
โป๏ธ Maximize lifestyle interventions: low-sodium diet (<2400 mg/day), at least 6 hours/night of
uninterrupted sleep, weight loss, exercise)
โป๏ธOptimize three-drug regimen of CCB, RAS inhibitor, and diuretic (appropriately dosed for
renal function) at maximally tolerated doses.
2โฃStep 2: Substitute optimally dosed thiazide diuretic (chlorthalidone or indapamide) for previous diuretic
3โฃStep 3: Add mineralocorticoid (aldosterone) receptor antagonist: spironolactone or eplerenone
4โฃStep 4:
๐ดIf heart rate โฅ70 beats/min, add ฮฒ-blocker
๐ดIf ฮฒ-blocker is contraindicated, add central ฮฑ1-agonist (clonidine or guanfacine)
5โฃStep 5: Add hydralazine and titrate to maximal dose (use concomitantly with a ฮฒ-blocker and diuretic)
6โฃStep 6: Substitute minoxidil for hydralazine and titrate
7โฃStep 7: Refer to HTN specialist or ongoing clinical trial
#BASEL
#ACCP -ASHP - Cardiology 2023
โค1
Forwarded from Dr. AL Sayed AL Grawany
Handbook of Nephrology and Hypertension ALGrawany 7E 2023 .pdf
24.3 MB
Handbook of Nephrology and Hypertension ALGrawany 7E 2023 .pdf
โค3๐1